Subclinical coronary artery disease in COVID-19 patients

Affiliations

¹ Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.
² Department of Radiology, SDN IRCCS, Naples, Italy.

Comment

Luca Nai Fovino et al. Eur Heart J Cardiovasc Imaging. 2020.

. 2020 Sep 1;21(9):1055-1056.

doi: 10.1093/ehjci/jeaa202.

¹ Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.
² Department of Radiology, SDN IRCCS, Naples, Italy.

No abstract available

Comment on

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Guo T, et al. JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017. JAMA Cardiol. 2020. PMID: 32219356 Free PMC article.

1. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z.. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;doi:10.1001/jamacardio.2020.1017. - PMC - PubMed
1. Sverzellati N, Cademartiri F, Bravi F, Martini C, Gira F, Maffei E, Marchianò A, La Vecchia C, De Filippo M, Kuhnigk JM, Rossi C, Pastorino U.. Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial. Radiology 2012;262:460–467. - PubMed